Proof-of-Concept Study of a Single Application of an Investigational Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes

NCT01908803 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

84

Enrollment

INDUSTRY

Sponsor class

Stopped Management decision

Conditions

Acute Otitis Media

Interventions

DRUG: AL-60371/AL-817 otic suspension
DRUG: Ciprofloxacin 0.3%/dexamethasone 0.1% otic suspension

Sponsor

Alcon Research